The Wolf Prize in Medicine is awarded annually by the Wolf Foundation in Israel. [1] It is one of the six Wolf Prizes established by the Foundation and awarded since 1978; the others are in Agriculture, Chemistry, Mathematics, Physics and Arts. The Prize has been stated to be the second most prestigious award in science, and a significant predictor of the Nobel Prize. [2]
Source: [3]
Year | Name | Nationality | Citation |
---|---|---|---|
1978 | George D. Snell | United States | for discovery of H-2 antigens, which codes for major transplantation antigens and the onset of the immune response. |
Jean Dausset | France | for discovering the HL-A system, the major histocompatibility complex in man and its primordial role in organ transplantation. | |
Jon J. van Rood | Netherlands | for his contribution to the understanding of the complexity of the HL-A system in man and its implications in transplantation and in disease. | |
1979 | Roger Wolcott Sperry | United States | for his studies on the functional differentiation of the right and left hemispheres of the brain. |
Arvid Carlsson | Sweden | for his work which established the role of dopamine as a neurotransmitter. | |
Oleh Hornykiewicz | Austria | for opening a new approach in the control of Parkinson's disease by L-Dopa. | |
1980 | César Milstein Leo Sachs James L. Gowans | Argentina / United Kingdom; Israel; United Kingdom | for their contributions to knowledge of the function and dysfunction of the body cells through their studies on the immunological role of the lymphocytes, the development of specific antibodies and the elucidation of mechanisms governing the control and differentiation of normal and cancer cells. |
1981 | Barbara McClintock | United States | for her imaginative and important contributions to our understanding of chromosome structure behaviour and function, and for her identification and description of transposable genetic (mobile) elements. |
Stanley N. Cohen | United States | for his concepts underlying genetic engineering; for constructing a biologically functional hybrid plasmid, and for achieving actual expression of a foreign gene implanted in E. coli by the recombinant DNA method. | |
1982 | Jean-Pierre Changeux | France | for the isolation, purification and characterization of the acetylcholine receptor. |
Solomon H. Snyder | United States | for the development of the ways to label neurotransmitter receptors which provide tools to describe their properties. | |
James W. Black | United Kingdom | for developing agents which block beta adrenergic and histamine receptors. | |
1983/4 | No award | ||
1984/5 | Donald F. Steiner | United States | for his discoveries concerning the bio-synthesis and processing of insulin which have had profound implications for basic biology and clinical medicine. |
1986 | Osamu Hayaishi | Japan | for his discovery of the oxygenase enzymes and elucidation of their structure and biological importance. |
1987 | Pedro Cuatrecasas Meir Wilchek | United States Israel | for the invention and development of affinity chromatography and its applications to biomedical sciences. |
1988 | Henri G. Hers Elizabeth F. Neufeld | Belgium United States | for the biochemical elucidation of lysosomal storage diseases and the resulting contributions to biology, pathology, prenatal diagnosis and therapeutics. |
1989 | John Gurdon | United Kingdom | for his introduction of the xenopus oocyte into molecular biology and his demonstration that the nucleus of a differentiated cell and of the egg differ in expression but not in the content of genetic material. |
Edward B. Lewis | United States | for his demonstration and exploration of the genetic control of the development of body segments by homeotic genes. | |
1990 | Maclyn McCarty | United States | for his part in the demonstration that the transforming factor in bacteria is due to deoxyribonucleic acid (DNA) and the concomitant discovery that the genetic material is composed of DNA. |
1991 | Seymour Benzer | United States | for having generated a new field of molecular neurogenetics by his pioneering research on the dissection of the nervous system and behavior by gene mutations. |
1992 | M. Judah Folkman | United States | for his discoveries which originated the concept and developed the field of angiogenesis research. |
1993 | No award | ||
1994/5 | Michael J. Berridge Yasutomi Nishizuka | United Kingdom Japan | for their discoveries concerning cellular transmembrane signalling involving phospholipids and calcium. |
1995/6 | Stanley B. Prusiner | United States | for discovering prions, a new class of pathogens that cause important neurodegenerative disease by inducing changes in protein structure. |
1997 | Mary Frances Lyon | United Kingdom | for her hypothesis concerning the random inactivation of X-chromosomes in mammals. |
1998 | Michael Sela Ruth Arnon | Israel Israel | for their major discoveries in the field of immunology. |
1999 | Eric R. Kandel | United States | for the elucidation of the organismic, cellular and molecular mechanisms whereby short-term memory is converted to a long-term form. |
2000 | No award | ||
2001 | Avram Hershko Alexander Varshavsky | Israel / Hungary; Russia / United States | for the discovery of the ubiquitin system of intracellular protein degradation and the crucial functions of this system in cellular regulation. |
2002/3 | Ralph L. Brinster | United States | for the development of procedures to manipulate mouse ova and embryos, which has enabled transgenesis and its applications in mice. |
Mario Capecchi Oliver Smithies | Italy / United States; United Kingdom / United States | for their contribution to the development of gene-targeting, enabling elucidation of gene function in mice. | |
2004 | Robert A. Weinberg | United States | for his discovery that cancer cells including human tumor cells, carry somatically mutated genes-oncogenes that operate to drive their malignant proliferation. |
Roger Y. Tsien | United States | for his seminal contribution to the design and biological application of novel fluorescent and photolabile molecules to analyze and perturb cell signal transduction. | |
2005 | Alexander Levitzki | Israel | for pioneering signal transduction therapy and for developing tyrosine kinase inhibitors as effective agents against cancer and a range of other diseases. |
Anthony R. Hunter | United Kingdom / United States | for the discovery of protein kinases that phosphorylate tyrosine residues in proteins, critical for the regulation of a wide variety of cellular events, including malignant transformation. | |
Anthony J. Pawson | United Kingdom / Canada | for his discovery of protein domains essential for mediating protein-protein interactions in cellular signaling pathways, and the insights this research has provided into cancer. | |
2006/7 | No award | ||
2008 | Howard Cedar Aharon Razin | United States Israel | for their fundamental contributions to our understanding of the role of DNA methylation in the control of gene expression. |
2009 | No award | ||
2010 | Axel Ullrich | Germany | for groundbreaking cancer research that has led to development of new drugs. |
2011 | Shinya Yamanaka Rudolf Jaenisch | Japan; Germany / United States | for the generation of induced pluripotent stem cells (iPS cells) from skin cells (SY) and demonstration that iPS cells can be used to cure genetic disease in a mammal, thus establishing their therapeutic potential (RJ). |
2012 | Ronald M. Evans | United States | for his discovery of the gene super-family encoding nuclear receptors and elucidating the mechanism of action of this class of receptors. |
2013 | No award | ||
2014 | Nahum Sonenberg | Israel / Canada | for his discovery of the proteins that control the protein expression mechanism and their operation. |
Gary Ruvkun Victor Ambros | United States; United States | for the discovery of the micro-RNA molecules that play a key role in controlling gene expression in natural processes and disease development. | |
2015 | John Kappler Philippa Marrack | United States; United States | for major contributions to the understanding of the key antigen-specific molecules, the T cell receptor for antigen and antibodies and how these molecules participate in immune recognition and effector function. |
Jeffrey Ravetch | United States | ||
2016 | C. Ronald Kahn | United States | for pioneering studies defining insulin signaling and its alterations in disease. |
Lewis C. Cantley | United States | for discovery of phosphoinositide- 3 kinases and their roles in physiology and disease. | |
2017 | James P. Allison | United States | for a revolution in cancer treatment due to the discovery of the immune control barrier. |
2018 | No award | ||
2019 | Jeffrey M. Friedman | United States | for the discovery of Leptin and the entirely new endocrine system controlling body weight (and many other processes). [4] |
2020 | Emmanuelle Charpentier | France | for deciphering and repurposing the bacterial CRISPR/Cas9 immune system for genome editing. |
Jennifer Doudna | United States | for revealing the medicine-revolutionizing mechanism of bacterial immunity via RNA-guided genome editing. [5] | |
2021 | Joan Steitz | United States | for her many fundamental contributions to the field of RNA biology. [6] |
Lynne Elizabeth Maquat | United States | for discovering a mechanism that destroys mutant messenger RNA in cells, nonsense-mediated mRNA decay. [6] | |
Adrian Krainer | Uruguay / United States | for his fundamental mechanistic discoveries on RNA splicing leading to a world’s first treatment for spinal muscular atrophy (SMA). [6] | |
2022 | No award | ||
2023 | Daniel J. Drucker | Canada | for pioneering work in elucidating the mechanisms and therapeutic potential of enteroendocrine hormones. [7] |
2024 | Botond Roska José-Alain Sahel | Hungary / Switzerland; France / United States | for sight-saving and vision restoration to blind people using optogenetics. [8] |
Below is a chart of all laureates per country (updated to 2024 laureates). Some laureates are counted more than once if they have multiple citizenships.
Country | Number of laureates |
---|---|
United States | 38 |
United Kingdom | 9 |
Israel | 8 |
France | 4 |
Japan | 3 |
Canada | 3 |
Germany | 2 |
Hungary | 2 |
Italy | 1 |
Argentina | 1 |
Netherlands | 1 |
Sweden | 1 |
Austria | 1 |
Belgium | 1 |
Uruguay | 1 |
Russia | 1 |
Switzerland | 1 |
The Nobel Prizes are five separate prizes awarded to those who, during the preceding year, have conferred the greatest benefit to humankind, as established by the 1895 will of Swedish chemist, engineer, and industrialist Alfred Nobel, in the year before he died. Prizes were first awarded in 1901 by the Nobel Foundation. Nobel's will indicated that the awards should be granted in the fields of Physics, Chemistry, Physiology or Medicine, Literature, and Peace. A sixth prize for Economic Sciences, endowed by Sweden's central bank, Sveriges Riksbank, and first presented in 1969, is also frequently included, as it is also administered by the Nobel Foundation. The Nobel Prizes are widely regarded as the most prestigious awards available in their respective fields.
The Nobel Prize in Physics is an annual award given by the Royal Swedish Academy of Sciences for those who have made the most outstanding contributions to mankind in the field of physics. It is one of the five Nobel Prizes established by the will of Alfred Nobel in 1895 and awarded since 1901, the others being the Nobel Prize in Chemistry, Nobel Prize in Literature, Nobel Peace Prize, and Nobel Prize in Physiology or Medicine. Physics is traditionally the first award presented in the Nobel Prize ceremony.
Stanley Ben Prusiner is an American neurologist and biochemist. He is the director of the Institute for Neurodegenerative Diseases at University of California, San Francisco (UCSF). Prusiner discovered prions, a class of infectious self-reproducing pathogens primarily or solely composed of protein, a scientific theory considered by many as a heretical idea when first proposed. He received the Albert Lasker Award for Basic Medical Research in 1994 and the Nobel Prize in Physiology or Medicine in 1997 for research on prion diseases developed by him and his team of experts beginning in the early 1970s.
The Wolf Prize is an international award granted in Israel, that has been presented most years since 1978 to living scientists and artists for "achievements in the interest of mankind and friendly relations among people ... irrespective of nationality, race, colour, religion, sex or political views."
The Japan Prize is awarded to individuals whose original and outstanding achievements in science and technology are recognized as having advanced the frontiers of knowledge and served the cause of peace and prosperity for mankind. As of 2024, the Japan Prize has been awarded to 111 people from more than ten countries.
The Wolf Prize in Mathematics is awarded almost annually by the Wolf Foundation in Israel. It is one of the six Wolf Prizes established by the Foundation and awarded since 1978; the others are in Agriculture, Chemistry, Medicine, Physics and Arts. The Wolf Prize includes a monetary award of $100,000.
The Wolf Prize in Arts is awarded annually by the not-for-profit Wolf Foundation in Israel. It is one of the six Wolf Prizes established by the Foundation, and has been awarded since 1981; the others are in Agriculture, Chemistry, Mathematics, Medicine and Physics, awarded since 1978. The Prize rotates annually among painting, music, architecture and sculpture.
The Wolf Prize in Physics is awarded once a year by the Wolf Foundation in Israel. It is one of the six Wolf Prizes established by the Foundation and awarded since 1978; the others are in Agriculture, Chemistry, Mathematics, Medicine and Arts.
The Wolf Prize in Chemistry is awarded annually by the Wolf Foundation in Israel. It is one of the six Wolf Prizes established by the Foundation and awarded since 1978; the others are in Agriculture, Mathematics, Medicine, Physics and Arts.
The Wolf Prize in Agriculture is awarded annually by the Wolf Foundation in Israel. It is one of the six Wolf Prizes established by the Foundation and awarded since 1978; the others are in Chemistry, Mathematics, Medicine, Physics and the Arts. The Prize is sometimes considered the equivalent of a "Nobel Prize in Agriculture".
The European Academy of Sciences and Arts is a transnational and interdisciplinary network, connecting about 2,000 recommended scientists and artists worldwide, including 38 Nobel Prize laureates. The European Academy of Sciences and Arts is a learned society of scientists and artists, founded by Felix Unger. The academy was founded 1990, is situated in Salzburg and has been supported by the city of Vienna, the government of Austria, and the European Commission. The EASA is now headed by President Klaus Mainzer, TUM Emeritus of Excellence at the Technical University of Munich and Senior Professor at the Carl Friedrich von Weizsäcker Center of the University of Tübingen.
Oliver Smithies was a British-American geneticist and physical biochemist. He is known for introducing starch as a medium for gel electrophoresis in 1955, and for the discovery, simultaneously with Mario Capecchi and Martin Evans, of the technique of homologous recombination of transgenic DNA with genomic DNA, a much more reliable method of altering animal genomes than previously used, and the technique behind gene targeting and knockout mice. He received the Nobel Prize in Physiology or Medicine in 2007 for his genetics work.
The Nobel Memorial Prize in Economic Sciences, officially the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel, is an economics award funded by Sveriges Riksbank and administered by the Nobel Foundation.
Aharon Razin was an Israeli biochemist.
The Nobel Prize in Chemistry is awarded annually by the Royal Swedish Academy of Sciences to scientists in the various fields of chemistry. It is one of the five Nobel Prizes established by the will of Alfred Nobel in 1895, awarded for outstanding contributions in chemistry, physics, literature, peace, and physiology or medicine. This award is administered by the Nobel Foundation, and awarded by the Royal Swedish Academy of Sciences on proposal of the Nobel Committee for Chemistry which consists of five members elected by the Academy. The award is presented in Stockholm at an annual ceremony on 10 December, the anniversary of Nobel's death.
Ada E. Yonath is an Israeli crystallographer and Nobel laureate in Chemistry, best known for her pioneering work on the structure of ribosomes. She is the current director of the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly of the Weizmann Institute of Science.
Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, the National Academy of Sciences and the National Academy of Medicine. She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester.
Emmanuelle Marie Charpentier is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing". This was the first science Nobel Prize ever won by two women only.